To study PD-L1 expression dynamics in the context of CART therapy, we examined tumor cells collected at the time of surgical resection from 14 patients with newly diagnosed or recurrent GBM at baseline and after exposure to the T-cell effector cytokine IFN-γ. Here, CD274 is linked to glioblastoma.